{
    "root": "20cf7fa9-42f3-4e7b-8a61-276858f9364f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Budesonide",
    "value": "20241115",
    "ingredients": [
        {
            "name": "BUDESONIDE",
            "code": "Q3OKS62Q6X"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (90000 WAMW)",
            "code": "UKE75GEA7F"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "HYPROMELLOSE 2910 (3 MPA.S)",
            "code": "0VUT3PMY82"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)",
            "code": "5KY68S2577"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 101",
            "code": "7T9FYH5QMK"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 102",
            "code": "PNR0YF693Y"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        }
    ],
    "indications": "budesonide extended-release tablets indicated induction remission patients active , mild moderate ulcerative colitis .",
    "contraindications": "recommended induction remission adult patients active , mild moderate ulcerative colitis one 9 mg tablet taken daily morning without food 8 weeks . ( 2.1 )",
    "warningsAndPrecautions": "budesonide extended-release tablets available containing 9 mg budesonide , usp . 9 mg tablets white , film-coated , round , unscored tablets be9 imprinted black ink one side tablet blank side . available follows : ndc 0378-4500-93bottles 30 tablets store 20° 25°c ( 68° 77°f ) . [ usp controlled room temperature . ] keep container tightly closed . protect light moisture . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "budesonide extended-release tablets contraindicated patients hypersensitivity budesonide ingredients budesonide extended-release tablets . anaphylactic occurred budesonide formulations [ ( 6.2 ) ] .",
    "indications_original": "Budesonide extended-release tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.",
    "contraindications_original": "The recommended dosage for the induction of remission in adult patients with active, mild to moderate ulcerative colitis is one 9 mg tablet to be taken once daily in the morning with or without food for up to 8 weeks. ( 2.1 )",
    "warningsAndPrecautions_original": "Budesonide Extended-Release Tablets are available containing 9 mg of budesonide, USP.\n                  The 9 mg tablets are white, film-coated, round, unscored tablets with M over BE9 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows:\n                  NDC 0378-4500-93bottles of 30 tablets\n                  \n                     Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]\n                  \n                  \n                     Keep container tightly closed. Protect from light and moisture.\n                  \n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Budesonide extended-release tablets are contraindicated in patients with hypersensitivity to budesonide or any of the ingredients of budesonide extended-release tablets. Anaphylactic reactions have occurred with other budesonide formulations [see \n                        Adverse Reactions (6.2)]."
}